In a large study of 429,595 adults aged 65 years or older, adjuvanted and high-dose influenza vaccines showed no significant ...

Knowing how many people are vaccinated against an existing or re-emerging threat is a key factor guiding public health decisions, but such information is often sparse or non-existent in many regions, ...

Researchers are working on a solution that could make vaccines easier to store and transport.

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.

Shionogi & Co. looks set to put its COVID-19 vaccine into practical use by the end of March 2022 following a government ...

For children — and many adults — the fear of injections remains a major barrier to vaccination. But research led by Elodie Segura, PhD, from the Immunity and Cancer Laboratory at the Institut Curie in ...

The recombinant zoster vaccine (Shingrix) is very effective against the viral rash, but research has found that it may also ...

A shingles shot may dramatically reduce the risk of heart attacks, strokes, and death in people with heart disease.